Landmark review of NHS dementia care reveals 'culture of containment' where patients are drugged and prevented from leaving ...

Dementia patients are given antipsychotics, which FDA warns may increase the risk for deat ...

Have you ever wondered how an Alzheimer’s patient literally views the world and what they experience in the confusion? Now, families and caregivers can have the experience through special goggles ...

The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for cognition or function in patients with early Alzheimer’s.

People with Alzheimer's disease often have other neurodegenerative conditions as well, including a less-understood disorder ...

Research roundtable highlights early detection, biomarkers, interventions ...

Stigma connected with Alzheimer’s disease may create barriers for individuals seeking information about their risk of the disease and discourage them from participating in clinical studies that could ...

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...

Scientists found microplastics in all examined human brains in a recent study, with highest levels discovered in dementia ...

Professor Fiona Carragher, chief policy and research officer at Alzheimer’s Society, said: “Rapid advancements in AI will give people affected by early-stage dementia the opportunity to stay safely in ...

False diagnoses are used to mask inappropriate use of antipsychotic drugs on patients with dementia, a practice called chemical restraint, a government watchdog report said.